BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12481980)

  • 1. I. Arginine.
    Tapiero H; Mathé G; Couvreur P; Tew KD
    Biomed Pharmacother; 2002 Nov; 56(9):439-45. PubMed ID: 12481980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.
    Fasehun OA; Gross SS; Rubin LE; Jaffe EA; Griffith OW; Levi R
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1348-53. PubMed ID: 2175803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-Arginine and its metabolites in kidney and cardiovascular disease.
    Popolo A; Adesso S; Pinto A; Autore G; Marzocco S
    Amino Acids; 2014 Oct; 46(10):2271-86. PubMed ID: 25161088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginase: a critical regulator of nitric oxide synthesis and vascular function.
    Durante W; Johnson FK; Johnson RA
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):906-11. PubMed ID: 17645639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic basis of arginine nutrition and pharmacotherapy.
    Flynn NE; Meininger CJ; Haynes TE; Wu G
    Biomed Pharmacother; 2002 Nov; 56(9):427-38. PubMed ID: 12481979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arginine--metabolism and functions in the human organism].
    Scibior D; Czeczot H
    Postepy Hig Med Dosw (Online); 2004; 58():321-32. PubMed ID: 15459550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine.
    Hecker M; Sessa WC; Harris HJ; Anggård EE; Vane JR
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8612-6. PubMed ID: 2236071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation.
    Schramm L; La M; Heidbreder E; Hecker M; Beckman JS; Lopau K; Zimmermann J; Rendl J; Reiners C; Winderl S; Wanner C; Schmidt HH
    Kidney Int; 2002 Apr; 61(4):1423-32. PubMed ID: 11918749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects.
    Lorin J; Zeller M; Guilland JC; Cottin Y; Vergely C; Rochette L
    Mol Nutr Food Res; 2014 Jan; 58(1):101-16. PubMed ID: 23740826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial toxins activation of abbreviated urea cycle in porcine cerebral vascular smooth muscle cells.
    Mishra RG; Tseng TL; Chen MF; Chen PY; Lee TJ
    Vascul Pharmacol; 2016 Dec; 87():110-120. PubMed ID: 27614253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans.
    Wu G; Meininger CJ; McNeal CJ; Bazer FW; Rhoads JM
    Adv Exp Med Biol; 2021; 1332():167-187. PubMed ID: 34251644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine nutrition and cardiovascular function.
    Wu G; Meininger CJ
    J Nutr; 2000 Nov; 130(11):2626-9. PubMed ID: 11053497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-arginine: a new opportunity in the management of clinical derangements in dialysis patients.
    Bellinghieri G; Santoro D; Mallamace A; Di Giorgio RM; De Luca G; Savica V
    J Ren Nutr; 2006 Jul; 16(3):245-7. PubMed ID: 16825029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered L-arginine/nitric oxide synthase/nitric oxide pathway in the vascular adventitia of rats with sepsis.
    Jia YX; Pan CS; Yang JH; Liu XH; Yuan WJ; Zhao J; Tang CS; Qi YF
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1202-8. PubMed ID: 17184502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium.
    Pieper GM; Peltier BA
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):397-403. PubMed ID: 7769804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic oral L-arginine administration on the L-arginine/NO pathway in patients with peripheral arterial occlusive disease or coronary artery disease: L-Arginine prevents renal loss of nitrite, the major NO reservoir.
    Schneider JY; Rothmann S; Schröder F; Langen J; Lücke T; Mariotti F; Huneau JF; Frölich JC; Tsikas D
    Amino Acids; 2015 Sep; 47(9):1961-74. PubMed ID: 26123989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant effects of dietary L-arginine on vascular structure and reactivity in hypercholesterolemic rabbits.
    Singer AH; Tsao PS; Wang BY; Bloch DA; Cooke JP
    J Cardiovasc Pharmacol; 1995 May; 25(5):710-6. PubMed ID: 7630149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism.
    Hesse M; Modolell M; La Flamme AC; Schito M; Fuentes JM; Cheever AW; Pearce EJ; Wynn TA
    J Immunol; 2001 Dec; 167(11):6533-44. PubMed ID: 11714822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine metabolism and nutrition in growth, health and disease.
    Wu G; Bazer FW; Davis TA; Kim SW; Li P; Marc Rhoads J; Carey Satterfield M; Smith SB; Spencer TE; Yin Y
    Amino Acids; 2009 May; 37(1):153-68. PubMed ID: 19030957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.